ECSP109871A - Soluciones farmacéuticas orales que contienen telbivudina - Google Patents

Soluciones farmacéuticas orales que contienen telbivudina

Info

Publication number
ECSP109871A
ECSP109871A EC2010009871A ECSP109871A ECSP109871A EC SP109871 A ECSP109871 A EC SP109871A EC 2010009871 A EC2010009871 A EC 2010009871A EC SP109871 A ECSP109871 A EC SP109871A EC SP109871 A ECSP109871 A EC SP109871A
Authority
EC
Ecuador
Prior art keywords
telbivudine
solutions containing
oral pharmaceutical
pharmaceutical solutions
thymidine
Prior art date
Application number
EC2010009871A
Other languages
English (en)
Inventor
Nabila Sekkat
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38724394&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP109871(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP109871A publication Critical patent/ECSP109871A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una solución farmacéutica adecuada para administración oral, la cual comprende ?-L-timidina/2'-desoxi-L-timidina (telbivudina), un sistema de solvente farmacéuticamente adecuado, uno o más agentes mejoradores/enmascaradores de sabor, un sistema conservador, y un sistema regulador adecuado para permitir tanto la estabilidad como la conservación del fármaco.
EC2010009871A 2007-07-12 2010-01-12 Soluciones farmacéuticas orales que contienen telbivudina ECSP109871A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07112381 2007-07-12

Publications (1)

Publication Number Publication Date
ECSP109871A true ECSP109871A (es) 2010-02-26

Family

ID=38724394

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2010009871A ECSP109871A (es) 2007-07-12 2010-01-12 Soluciones farmacéuticas orales que contienen telbivudina

Country Status (22)

Country Link
US (1) US8445457B2 (es)
EP (1) EP2178503A1 (es)
JP (1) JP5314014B2 (es)
KR (3) KR20120078754A (es)
CN (1) CN101686938B (es)
AR (1) AR067630A1 (es)
AU (1) AU2008274170B2 (es)
BR (1) BRPI0815562A2 (es)
CA (1) CA2693609A1 (es)
CL (1) CL2008002025A1 (es)
CO (1) CO6270204A2 (es)
EC (1) ECSP109871A (es)
IL (1) IL202961A (es)
MA (1) MA31507B1 (es)
MY (1) MY147366A (es)
NZ (1) NZ582443A (es)
PE (2) PE20090476A1 (es)
RU (1) RU2493826C2 (es)
TN (1) TN2010000008A1 (es)
TW (1) TW200911302A (es)
WO (1) WO2009007426A1 (es)
ZA (1) ZA200908993B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY173181A (en) 2011-05-13 2020-01-02 Array Biopharma Inc Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
US20140107130A1 (en) * 2012-10-11 2014-04-17 Antrim Pharmaceuticals, LLC Oral Solution Formulations of Aripiprazole
LT3154959T (lt) 2014-05-15 2019-09-25 Array Biopharma, Inc. 1-((3s,4r)-4-(3-fluorfenil)-1-(2-metoksietil)pirolidin-3-il)-3-(4-metil-3-(2-metilpirimidin-5-il)-1-fenil-1h-pirazol-5-il)karbamidas kaip trka kinazės inhibitorius
JP6526904B2 (ja) * 2015-04-26 2019-06-05 マッカイ メモリアル ホスピタルＭａｃｋａｙ Ｍｅｍｏｒｉａｌ Ｈｏｓｐｉｔａｌ 腎疾患を有する患者の腎臓及び／又は心臓機能の改善方法
CN107550866A (zh) * 2016-06-30 2018-01-09 康普药业股份有限公司 一种替比夫定制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856364A (en) 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same
EP1023899A1 (en) * 1997-09-26 2000-08-02 Wakamoto Pharmaceutical Co., Ltd. Aqueous preparation containing antiviral agent having purine or pyrimidine skeleton
DE19817265A1 (de) 1998-04-18 1999-10-21 Bayer Ag Verwendung von Dihydropyrimidinen als Arzneimittel und neue Stoffe
DE19817264A1 (de) 1998-04-18 1999-10-21 Bayer Ag Neue Dihydropyrimidine
PE20030545A1 (es) * 2001-10-31 2003-06-19 Schering Corp Formulaciones de jarabe de ribavirina
TWI244393B (en) 2002-08-06 2005-12-01 Idenix Pharmaceuticals Inc Crystalline and amorphous forms of beta-L-2'-deoxythymidine
WO2006130217A2 (en) 2005-04-01 2006-12-07 The Regents Of The University Of California Substituted phosphate esters of nucleoside phosphonates

Also Published As

Publication number Publication date
JP5314014B2 (ja) 2013-10-16
BRPI0815562A2 (pt) 2015-02-18
PE20090476A1 (es) 2009-05-12
KR20120078754A (ko) 2012-07-10
TW200911302A (en) 2009-03-16
CN101686938A (zh) 2010-03-31
KR20140019040A (ko) 2014-02-13
CO6270204A2 (es) 2011-04-20
CL2008002025A1 (es) 2009-05-08
EP2178503A1 (en) 2010-04-28
AR067630A1 (es) 2009-10-21
US8445457B2 (en) 2013-05-21
NZ582443A (en) 2011-04-29
IL202961A (en) 2013-10-31
AU2008274170B2 (en) 2011-06-09
RU2493826C2 (ru) 2013-09-27
RU2010104395A (ru) 2011-08-20
TN2010000008A1 (en) 2011-09-26
ZA200908993B (en) 2010-09-29
JP2010533146A (ja) 2010-10-21
CN101686938B (zh) 2012-09-05
WO2009007426A1 (en) 2009-01-15
CA2693609A1 (en) 2009-01-15
MY147366A (en) 2012-11-30
PE20130180A1 (es) 2013-03-06
KR20100029829A (ko) 2010-03-17
US20100197629A1 (en) 2010-08-05
AU2008274170A1 (en) 2009-01-15
MA31507B1 (fr) 2010-07-01

Similar Documents

Publication Publication Date Title
AR059359A1 (es) Formulaciones farmaceuticas que contienen pleconaril
AR059357A1 (es) Formulaciones farmaceuticas
MA28921B1 (fr) Derive heterocyclique azote et medicament le contenant en tant que principe actif
MX2009010289A (es) Composiciones para administracion nasal.
DE602005010788D1 (de) Pharmazeutische Zusammensetzungen zur sicheren Verabreichung von bei der Behandlung von Drogenabhängigkeit verwendeten Arzneimitteln
AR042066A1 (es) Dispositivo conector
CL2011000170A1 (es) Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa.
UY30759A1 (es) Compuestos quimicos
CL2008003595A1 (es) Compuestos heterociclicos nitrogenados, antagonistas del receptor de taquiquinina; agente farmaceutico que comprende el compuesto; y uso en la profilaxis o el tratamiento de una enfermedad del tracto urinario inferior, una enfermedad gastrointestinal o una enfermedad del sistema nervioso central.
CL2008001297A1 (es) N-[(1s)-1-(5-fluoropirim idin-2-i1 )etil]-3-(5-isopropoxi-1 h-pirazol-3-il )-3h-imidazo[4,5-b]piridin-5amina o una sal farmacéuticamente aceptabie del mismo; composición farmacéutica que lo comprende; y su uso en el tratamiento del cáncer.
AR065246A1 (es) Composiciones para mejorar la absorcion gastrointestinal de nutrientes y de farmacos
EA201200096A1 (ru) Фармацевтическая композиция ингибитора протеазы вируса гепатита c
AR047928A1 (es) Derivados de tetrahidropiridoindol
LTPA2019508I1 (lt) Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui
ECSP109871A (es) Soluciones farmacéuticas orales que contienen telbivudina
IN2012DN00359A (es)
ES2531241T3 (es) Composición farmacéutica líquida estable a base de trazodona
NO20081559L (no) Kit for parenteral administrering av medikamenter
NO20070831L (no) Middel for aktivering av tilfriskning fra dysfunksjon etter starten av sentralnevrologisk sykdom.
AR033596A1 (es) Composicion farmaceutica para inyeccion intramuscular que contiene loxoprofeno
ES2325291A1 (es) "uso de un extracto de silybum marianum"
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
AR048672A1 (es) Tabletas de desintegracion que comprenden licarbazepina
DE602006012310D1 (de) An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungen
SE0203817D0 (sv) New composition